Media OutReach Newswire

2024-10-07 09:30

Phase III clinical data of AIM Vaccine iterative serum-free rabies vaccine reaches preset goals

It is expected to become the world’s first heavyweight iteration of a major item to be launched on the market

HONG KONG SAR - Media OutReach Newswire - 7 October 2024 - AIM Vaccine announced on the evening of October 6 that the company has received notification from the National Institutes for Food and Drug Control on the serum antibody test results of the phase III clinical trial of the iterative serum-free rabies vaccine. The unblinding and statistical analysis of the phase III clinical trial data have been completed. The results showed that the vaccine had good immunogenicity and safety, and reached the preset clinical goals. At present, no serum-free rabies vaccine has been approved for marketing in the global market, the product is expected to become the world's first listed iteration of the big single product, becoming a milestone of major technological innovation in the industry.

According to the announcement, the iterative serum-free rabies vaccine has completed the preliminary work for marketing registration, and has undergone process verification in the GMP workshop that meets the marketing scale and quality requirements. The pre-inspection results for drug registration meet the quality standards. The company will submit the application for listing registration of the product as soon as possible.

Completely unlike the existing Vero cell rabies vaccine containing serum and human diploid rabies vaccine containing serum, the iterative serum-free rabies vaccine is an iterative product. Animal serum residues in vaccine products are one of the important factors leading to adverse reactions such as allergies in vaccinated populations, and the iterative serum-free rabies vaccine developed by the Company does not contain animal serum, which significantly improves safety and reduces the probability of adverse reactions.

According to the company's 2024 interim report, with respect to rabies vaccines in China, the approved lot release volume increased from 58.80 million in 2019 to 78.50 million in 2021, representing an increase of 33.6%. It is expected that the market scale will increase to RMB22.0 billion by 2030. This is mainly Benefit from the iterative upgrade of rabies vaccine products. Meanwhile, the development of serum-free rabies vaccines will also drive market growth. It has adopted the serum-free cell cultivation technology and has more stable compositions and higher safety, and it is expected that the technology will account for approximately 35.0% of the rabies vaccine market in China by 2030.

This year is a year of intensive application for Aimi vaccines. Three heavyweight single-product vaccines, including iterative serum-free rabies vaccine, are accelerating their application for listing. The accelerated launch process of new products is expected to become a new performance growth point for the company.

Hashtag: #AIM

發佈者對本公告的內容承擔全部責任

source: AIM Vaccine

【你點睇?】美國總統特朗普批評烏克蘭總統澤連斯基是「一位未經選舉的獨裁者」,俄烏戰爭早應停止。你是否認同特朗普的說法?► 立即投票

人氣文章
最近7天
沒有相關資料。
1
港股 | 蕭猷華:內地AI發展迅速,阿里巴巴股價看俏
2
高息定存 | 一周高息合集,銀行高息搶存,富邦1個月4.88厘,華僑1年期3.6厘
3
英偉達 | DeepSeek衝擊AI晶片行業結構 英偉達暴跌仍未急抄底
4
環球央行 | 歐洲央行宣布再次減息0.25厘,符合市場預期
5
一本萬利 | 2025年的五個「勿」(有片)
6
啟德體育園明天足球賽測試,4.4萬公僕參與涉逾400萬車馬費
7
高息定存 | 華僑銀行推新春港元定存優惠,88天或188天享3.68厘
8
電騙 | 黃俊碩:多管齊下,防治內地留學生受騙
9
易經看世界 | 乙巳蛇年趨吉五招:言行注意甚麼?應遠離甚麼人?(有片)
10
PapaHome淘寶家具實體店22日開幕,選址尖沙咀中港城,料創100個就業機會
11
新世界 | 摩通:新世界若債務違約或打開行業「潘朵拉盒子」
12
專訪 | 關稅戰 | 香港物流協會副會長梁庭彰:美物流商停收包裹對跨境電商打擊重大
13
【FOCUS】螺絲殼裏做道場,DeepSeek致勝啟示
14
港股 | 午市前瞻 | iPhone SE難救中國市場 專家提醒比電已超買
15
大S | 台灣藝人徐熙媛因流感併發肺炎逝世,享年48歲
16
DeepSeek推出即上蘋果中國區榜首,能力直追OpenAI
17
收市短打 | 楊韻銳:港股升勢有成交配合 惟留意關鍵阻力位!
18
高息定存 | 一周高息合集,蛇年定存金蛇起舞,1個月定存高達8厘
19
港股 | 蕭猷華:春節假後,恒指逐步上望21000點
20
馬斯克明拆特朗普台,指其星際之門計劃「假大空」
21
【FOCUS】侵侵呼籲全球「降息」,日銀祭18年最激進加息
22
神州經脈 | 特朗普或與華討論關稅,人民幣大漲,滬指連升兩周
23
港股 | 午市前瞻 | AI應用概念炒作有錢途 下階段部署邊隻好?
24
港股 | 午市前瞻 | DeepSeek概念火爆炒起AI股 百度係時候追落後
25
DeepSeek | 從私募孵化的AI新星--DeepSeek崛起之路
26
高息定存 | 信銀國際1個月加至3.85厘,華僑一年期3.6厘
27
隱瞞「賣殼」欺詐罪成,詹培忠判囚34個月,詹劍崙囚37個月
28
阿里 | 推新AI模型聲稱超越DeepSeek,股價逆市飆逾半成仍有上升空間?
29
【FOCUS】中長期資金入市首提硬指標,健康慢牛仍需解兩難
30
魚缸博客 | Deepseek改變AI?繼續買芯片股!衝啊!
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

【etnet 30周年】多重慶祝活動一浪接一浪,好禮連環賞!

etnet榮獲第六屆國際信息商會議「最佳信息商」白金獎

etnet榮獲HKEX Awards 2023 「最佳證券數據供應商」大獎

大國博弈

2025-26年度財政預算案

貨幣攻略

說說心理話

Watch Trends 2024

北上食買玩

Art Month 2024

理財秘笈

流感高峰期

山今養生智慧

輕鬆護老